|
COMMERCE BUSINESS DAILY ISSUE OF AUGUST 22,1997 PSA#1915National Cancer Institute, Research Contracts Branch, PSCS, 6120
Executive Blvd, Eps/room 638, Bethesda, MD 20892-7227 A -- ASSESS BREAST CANCER CASE-CONTROL DIFFERENCES IN LEVELS OF
INSULIN-LIKE GROWTH FACTORS SOL RFQ-70164-NV DUE 090597 POC Debbie
Moore, Purchasing Agent, 301-402-4509, Trish Haun, Contracting Officer
301-402-4509 The National Cancer Institute intends to enter into an
agreement with McGill University, Department of Medicine, Quebec,
Canada to assess case-control differences in serum levels of IGF-I,
IGF-II, IGFBP1, and IGFBP3. This is a follow-on purchase to an order
entitled "IGF Validity, Quality Control and Feasibility." Changing
laboratories would be detrimental to the current research as the
results would not be comparable. Due to continuity of an on-going
experiment the Government intends to award as sole source procurement
to McGill University. This in not a request for proposals, but rater a
notice of intent. However, organizations who believe they can meet
this need may submit a proposal with all evaluative materials to Debbie
Moore, 6120 Executive Blvd., Rm. 634, Rockville, MD 20892-7227 no later
than September 5, 1997 at 1:00 PM EST. No collect calls will be
accepted. See Note 22. (0232) Loren Data Corp. http://www.ld.com (SYN# 0011 19970822\A-0011.SOL)
A - Research and Development Index Page
|
|